Form D · Biotechnology
Insulete, Inc.
Madison, WI · CIK 0001674224
Offering snapshot reported May 10, 2016 · SEC filing
- Reported sold
- $300K Offering amount: $300K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $300K Reported outside-investor minimum
- First sale
- Apr 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2016 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $24K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-262881
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| M. Barc Investment Group, Inc. | 41082 | M. Barc Investment Group, Inc. · CRD 41082 |
Source: Form D, filed May 10, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jay Handy | Director, Executive |
| Gregory J. Lynch | Executive |
| Jeffrey B. Rusinow | Director, Executive |
| Hans W. Sollinger | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3330 University Avenue Suite 120
Madison, WI, 53705
Madison, WI, 53705